A Randomized Double-Blind, Placebo-Controlled Study on Anti-Stress Effects of Nelumbinis Semen

被引:0
|
作者
Ye, Minsook [1 ]
Bae, Hyunsu [2 ]
Park, Songyi [3 ]
Lew, Jaehwan [3 ]
Kim, Kyung Soo [1 ,4 ]
Shim, Insop [5 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul 06591, South Korea
[2] Kyung Hee Univ, Coll Korean Med, Dept Physiol, Seoul 02447, South Korea
[3] Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med, Yongin 17104, South Korea
[4] Catholic Univ Korea, Coll Med, Dept Family Med, Seoul 06591, South Korea
[5] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
nelumbinis semen (NS); depressive disorder; Beck depression inventory (BDI); electroencephalography (EEG); stress response inventory (SRI); CHRONIC MILD STRESS; RATS; INVENTORY;
D O I
10.3390/ijerph19137963
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Introduction: Depression is a serious and common mental disease that causes low mood and loss of interest in activities. Nelumbinis semen (NS) has been widely used as a treatment for depression for hundreds of years in many Asian countries. Water extract of nelumbinis semen (WNS) is a standardized herbal medicine made from NS. Methods: The objective of the present research was to perform a randomized, double-blind, placebo-controlled trial to estimate the efficacy of WNS for improving depressive and stress symptoms using Beck depression inventory (BDI) and the stress response inventory (SRI) in 45 adults diagnosed with major depression or other forms of depressive disorders. They were randomized to either a placebo-treated group, a 2.4 g per day WNS-treated group, or a 4.8 g per day WNS-treated group. BDI and SRI were determined in order to evaluate changes in depression before and after two weeks of WNS treatment. Results: The average BDI and SRI of the 2.4 g WNS-treated group were significantly (p < 0.05) improved compared to those of the placebo-treated group. Their BDI subscale A (negative attitudes towards self) and subscale C (somatic disturbances), SRI E, and depression subscale of SRI were substantially shorter (p < 0.05). In addition, an analysis of collected EEG data of participants showed a significant increase in alpha/beta activity in the 4.8 g WNS-treated group, which might be explained as an advancement of their depression symptoms (p < 0.05). Conclusions: These results suggest that WNS treatment can decrease depression. Our study provides preliminary evidence for the safety of WNS and its potential to decrease depression.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] SIAXI Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea
    Jost, Wolfgang H.
    Friedman, Andrzej
    Michel, Olaf
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Pagan, Fernando
    Flatau-Baque, Birgit
    Csikos, Janos
    Cairney, Claire J.
    Blitzer, Andrew
    NEUROLOGY, 2019, 92 (17) : E1982 - E1991
  • [32] Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
    Rammohan, KW
    Lynn, DJ
    NEUROLOGY, 2005, 65 (12) : 1995 - 1996
  • [33] A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis
    Carter, Melody C.
    Maric, Irina
    Brittain, Erica H.
    Bai, Yun
    Lumbard, Keith
    Bolan, Hyejeong
    Cantave, Daly
    Scott, Linda M.
    Metcalfe, Dean D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) : 1004 - +
  • [34] A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia
    Sabe, L
    Salvarezza, F
    Cuerva, AG
    Leiguarda, R
    Starkstein, S
    NEUROLOGY, 1995, 45 (12) : 2272 - 2274
  • [35] Transdermal nicotine in PD: A randomized, double-blind, placebo-controlled study
    Allam, MF
    NEUROLOGY, 2002, 58 (07) : 1133 - 1133
  • [36] Montelukast for migraine prophylaxis: A randomized, double-blind, placebo-controlled study
    Brandes, JL
    Visser, WH
    Farmer, MV
    Schuhl, AL
    Malbecq, W
    Vrijens, F
    Lines, CR
    Reines, SA
    HEADACHE, 2004, 44 (06): : 581 - 586
  • [37] Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine
    Whitmarsh, TE
    ColestonShields, DM
    Steiner, TJ
    CEPHALALGIA, 1997, 17 (05) : 600 - 604
  • [38] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
    Shervin Taslimi
    Hamed Vahidi
    Ali Pourvaziri
    Amirhossein Modabbernia
    Arezoo Yeke Fallah
    Nasrin Yazdani
    Negin Taslimi
    Mostafa Hosseini
    Masoud Motesadi Zarandi
    European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1635 - 1641
  • [39] Oxcarbazepine in migraine headache - A double-blind, randomized, placebo-controlled study
    Silberstein, S.
    Saper, J.
    Berenson, F.
    Somogyi, M.
    McCague, K.
    D'Souza, J.
    NEUROLOGY, 2008, 70 (07) : 548 - 555
  • [40] Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
    KH Staubach
    J Schröder
    P Zabel
    F Stüber
    Critical Care, 2 (Suppl 1):